Ilika sets industrial pace with new solid state battery programme

Ilika Plc

Ilika has unveiled its PRIMED programme, a focused initiative designed to accelerate progress of its Goliath solid state battery technology. Backed by government funding and guided by industry and academic partners, the company has set out a 12-month timetable to deliver prototype cells that can move it closer to commercial viability.

The programme will run at the UK Battery Industrialisation Centre, giving Ilika access to facilities that replicate early stages of large-scale production. Within this framework, the company intends to produce its next generation of P2 prototype cells and assemble 50 amp-hour A-samples that can be evaluated for use in electric vehicles.

An important aspect of PRIMED is the steering committee put in place to oversee direction. Jaguar Land Rover brings an automotive perspective, ensuring design choices and specifications remain aligned with the requirements of future electric platforms. Oxford University, represented by Professor Paul Shearing, adds an academic lens to strengthen technical oversight and maintain scientific rigour.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Search